Chronic Treatment with the AMPK Agonist AICAR Prevents Skeletal Muscle Pathology but Fails to Improve Clinical Outcome in a Mouse Model of Severe Spinal Muscular Atrophy-Reference-Cited by-同舟云学术

Chronic Treatment with the AMPK Agonist AICAR Prevents Skeletal Muscle Pathology but Fails to Improve Clinical Outcome in a Mouse Model of Severe Spinal Muscular Atrophy

Published:2015-11-18 Issue:1 Volume:13 Page:198-216
ISSN:1933-7213
Container-title:Neurotherapeutics
language:en
Short-container-title:Neurotherapeutics

Author:

Cerveró Clàudia,Montull Neus,Tarabal Olga,Piedrafita Lídia,Esquerda Josep E.,Calderó Jordi

Funder

Ministerio de Economía y Competitividad and FEDER

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s13311-015-0399-x.pdf

Reference111 articles.

1. Emery AE. Population frequencies of inherited neuromuscular diseases—a world survey. Neuromuscul Disord 1991;1:19-29.

2. Crawford TO, Pardo CA. The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 1996;3:97-110.

3. Lefebvre S, Burglen L, Reboullet S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995;80:155-165.

4. Pellizzoni L, Kataoka N, Charroux B, Dreyfuss G. A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell 1998;95:615-624.

5. Kolb SJ, Battle DJ, Dreyfuss G. Molecular functions of the SMN complex. J Child Neurol 2007;22:990-994.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ubiquitination Insight from Spinal Muscular Atrophy—From Pathogenesis to Therapy: A Muscle Perspective;International Journal of Molecular Sciences;2024-08-13

2. A transcriptomics-based drug repositioning approach to identify drugs with similar activities for the treatment of muscle pathologies in spinal muscular atrophy (SMA) models;Human Molecular Genetics;2023-11-08

3. Sarcopenic obesity: emerging mechanisms and therapeutic potential;Metabolism;2023-09

4. AMPK is mitochondrial medicine for neuromuscular disorders;Trends in Molecular Medicine;2023-07

5. Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice;Skeletal Muscle;2022-07-28